These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7964690)
1. Changes in aminergic receptors in a PSP postmortem brain: correlation with pathological findings. Pascual J; Figols J; Grijalba B; González AM; del Olmo E; Berciano J; Pazos A J Neural Transm Suppl; 1994; 42():247-60. PubMed ID: 7964690 [TBL] [Abstract][Full Text] [Related]
2. Autoradiographic demonstration of loss of alpha 2-adrenoceptors in progressive supranuclear palsy: preliminary report. Pascual J; Berciano J; González AM; Grijalba B; Figols J; Pazos A J Neurol Sci; 1993 Feb; 114(2):165-9. PubMed ID: 8095296 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Pascual J; Berciano J; Grijalba B; del Olmo E; González AM; Figols J; Pazos A Ann Neurol; 1992 Nov; 32(5):703-7. PubMed ID: 1449252 [TBL] [Abstract][Full Text] [Related]
4. Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy. Landwehrmeyer B; Palacios JM J Neural Transm Suppl; 1994; 42():229-46. PubMed ID: 7525868 [TBL] [Abstract][Full Text] [Related]
5. Multireceptor fingerprints in progressive supranuclear palsy. Chiu WZ; Donker Kaat L; Boon AJW; Kamphorst W; Schleicher A; Zilles K; van Swieten JC; Palomero-Gallagher N Alzheimers Res Ther; 2017 Apr; 9(1):28. PubMed ID: 28412965 [TBL] [Abstract][Full Text] [Related]
6. Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy. Warren NM; Piggott MA; Greally E; Lake M; Lees AJ; Burn DJ Mov Disord; 2007 Aug; 22(11):1594-600. PubMed ID: 17534953 [TBL] [Abstract][Full Text] [Related]
7. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
8. Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy. Lin WY; Lin KJ; Weng YH; Yen TC; Shen LH; Liao MH; Lu CS Nucl Med Commun; 2010 Nov; 31(11):974-80. PubMed ID: 20717064 [TBL] [Abstract][Full Text] [Related]
9. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321 [TBL] [Abstract][Full Text] [Related]
10. Tau and saitohin gene expression pattern in progressive supranuclear palsy. Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831 [TBL] [Abstract][Full Text] [Related]
11. Cholinergic vesicular transporters in progressive supranuclear palsy. Suzuki M; Desmond TJ; Albin RL; Frey KA Neurology; 2002 Apr; 58(7):1013-8. PubMed ID: 11940684 [TBL] [Abstract][Full Text] [Related]
12. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857 [TBL] [Abstract][Full Text] [Related]
13. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936 [TBL] [Abstract][Full Text] [Related]